MichaelJamieHochmanMD(He/Him)

PubMed

• SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes.
  Michael J Hochman, Amy E DeZern> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 18
• Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
  Michael J Hochman, Megan Othus, Robert P Hasserjian, Alex Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elih...> ;Leukemia. 2023 Sep 1
• 1 citations
  The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelod...
  Sandeep Gurbuxani, Michael J Hochman, Amy E DeZern, Akiko Shimamura> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
• 1 citations
  On the basis of sex: outcomes in myelodysplastic syndromes.
  Michael J Hochman, Amy E DeZern> ;The Lancet. Haematology. 2023 Feb 1
• 11 citations
  Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?
  Michael J Hochman, Amy E DeZern> ;The Lancet. Haematology. 2022 Jul 1
• 3 citations
  Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
  Michael J Hochman, B Douglas Smith, Theodoros Karantanos, Evan M Braunstein, Ivana Gojo, Tania Jain, Michael B Streiff, Alison R Moliterno, Amy E DeZern> ;International Journal of Hematology. 2023 Mar 1
• 4 citations
  Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms.
  Michael J Hochman, Bipin N Savani, Tania Jain> ;Ejhaem. 2021 Aug 1
• 2 citations
  Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML).
  Michael Hochman, Megan Othus, Roland B. Walter, Carole Shaw, Kelda M. Gardner, Mary-Elizabeth M. Percival, Anna B. Halpern, Paul C. Hendrie, Brenda M. Sandmaier, Elihu...> ;Leukemia & Lymphoma. 2021 Mar 22
• 56 citations
  Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies.
  Michael J. Hochman, Yinxi Yu, Steven Wolf, Greg Samsa, Arif H. Kamal, Thomas W. LeBlanc> ;Journal of Pain and Symptom Management. 2018 Jan 1
• Join now to see all

Lectures

• Does intensity of induction chemotherapy affect the impact of measurable residual disease (MRD) on prognosis in acute myeloid leukemia (AML)? 
  2019 ASCO Annual Meeting - 6/1/2019